Media Summary: contains the full versions of the congress talks International Symposium On: Modern Disease ... As the first of its kind, the Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP Testing, of Ileana L. Piña, MD, MPH, discusses the need to implement the findings of

Prof Andrew Js Coats On The Strong Hf Study - Detailed Analysis & Overview

contains the full versions of the congress talks International Symposium On: Modern Disease ... As the first of its kind, the Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP Testing, of Ileana L. Piña, MD, MPH, discusses the need to implement the findings of Amanda Vest, MBBS, MPH interviews Alexandre Mebazaa, MD, PhD about the results of European Heart Journal - EHJ Today: Stefan Agewall and Martin Cowie on SERVE- During the American Heart Association Late-Breaking Scientific Sessions in November 2022, the results of the Safety, Tolerability ...

Eric J. Velazquez, MD, Robert W. Berliner

Photo Gallery

Prof. Andrew JS Coats on the STRONG-HF study
Multi-center RCT of the Efficacy of LV Augmentation with Algisyl in the Treatment of HF
Andrew Justin Stewart COATS: "Management of comorbidities in ischaemic heart disease"
ESC 2020: Improving Heart Failure Outcomes — Prof Andrew Coats
ESN Cleer FY22 AGM - Professor Andrew Coats, Jan 2023
HFA online education: Introduction to best practice
AHA 22: Late-Breaker Discussion: The STRONG-HF Trial
Understanding the STRONG-HF clinical study
STRONG HF This Is the Science  Lets Get It Done
CFR: A Message From the Editor-in-Chief
STRONG-HF Results
EHJ Today - SERVE-HF Study Results
View Detailed Profile
Prof. Andrew JS Coats on the STRONG-HF study

Prof. Andrew JS Coats on the STRONG-HF study

Heart failure

Multi-center RCT of the Efficacy of LV Augmentation with Algisyl in the Treatment of HF

Multi-center RCT of the Efficacy of LV Augmentation with Algisyl in the Treatment of HF

AUGMENT-

Andrew Justin Stewart COATS: "Management of comorbidities in ischaemic heart disease"

Andrew Justin Stewart COATS: "Management of comorbidities in ischaemic heart disease"

http://www.fondazione-menarini.it/ contains the full versions of the congress talks International Symposium On: Modern Disease ...

ESC 2020: Improving Heart Failure Outcomes — Prof Andrew Coats

ESC 2020: Improving Heart Failure Outcomes — Prof Andrew Coats

Prof Andrew Coats

ESN Cleer FY22 AGM - Professor Andrew Coats, Jan 2023

ESN Cleer FY22 AGM - Professor Andrew Coats, Jan 2023

Prof Coats

HFA online education: Introduction to best practice

HFA online education: Introduction to best practice

Professor Andrew Coats

AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Visit Radcliffe Cardiology: ...

Understanding the STRONG-HF clinical study

Understanding the STRONG-HF clinical study

As the first of its kind, the Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP Testing, of

STRONG HF This Is the Science  Lets Get It Done

STRONG HF This Is the Science Lets Get It Done

Ileana L. Piña, MD, MPH, discusses the need to implement the findings of

CFR: A Message From the Editor-in-Chief

CFR: A Message From the Editor-in-Chief

Hear from

STRONG-HF Results

STRONG-HF Results

Amanda Vest, MBBS, MPH interviews Alexandre Mebazaa, MD, PhD about the results of

EHJ Today - SERVE-HF Study Results

EHJ Today - SERVE-HF Study Results

European Heart Journal - EHJ Today: Stefan Agewall and Martin Cowie on SERVE-

The HF nurse at the heart of HF care: excellence in action! #HeartFailure26

The HF nurse at the heart of HF care: excellence in action! #HeartFailure26

HF

ESC 24 Hot Line Discussion: The FINEARTS-HF Trial

ESC 24 Hot Line Discussion: The FINEARTS-HF Trial

ESC Congress 2024 — FINEARTS-

Help reduce Heart Failure readmissions at your institution: a STRONG recommendation

Help reduce Heart Failure readmissions at your institution: a STRONG recommendation

During the American Heart Association Late-Breaking Scientific Sessions in November 2022, the results of the Safety, Tolerability ...

THT 25: The RELIEVE-HF Study

THT 25: The RELIEVE-HF Study

THT Conference 2025 - Outcomes after

Eric J. Velazquez, MD: PIONEER-HF Results for Acute Decompensated HF

Eric J. Velazquez, MD: PIONEER-HF Results for Acute Decompensated HF

Eric J. Velazquez, MD, Robert W. Berliner

International Academy of Cardiology: Andrew J. Taylor, Ph.D.: CARDIAC FIBROSIS IN HEART FAILURE

International Academy of Cardiology: Andrew J. Taylor, Ph.D.: CARDIAC FIBROSIS IN HEART FAILURE

CARDIAC FIBROSIS IN